DMAC Competitors & Alternatives
Compare DiaMedica Therapeutics Inc with similar stocks in the same industry
Biotechnology
DMAC
Main Stock$6.28
Tradestie Score
59
Market Cap
$354.59M
Analyst Upside
+146.8%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$17.75
|
$354.45M | - | 60 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$30.60
|
$353.70M | - | 58 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.80
|
$350.98M | - | 62 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.91
|
$341.56M | - | 59 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.28
|
$332.96M | - | 53 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.42
|
$328.62M | - | 63 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.08
|
$304.12M | - | 61 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.97
|
$297.23M | - | 50 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$30.59
|
$293.03M | - | 58 | Compare |
|
OMER
Omeros Corporation
|
$10.48
|
$281.75M | 9.1 | 57 | Compare |
More DMAC Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry